Pfizer to Acquire Encysive Pharmaceuticals BUSINESS WIRE Posted: 2008-02-20 09:26:41 NEW YORK & HOUSTON--(BUSINESS WIRE)----Pfizer Inc today announced that it has entered into an agreement to acquire Encysive Pharmaceuticals Inc. (NASDAQ: ENCY), a publicly held biopharmaceutical company whose product for the treatment of pulmonary arterial hypertension (PAH) is commercially available in much of the European Union and is approved in other markets.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.